Abstract

The transfusion of platelet concentrates prepared from allogeneic single or pooled donations is a standard procedure in transfusion medicine to stop or prevent bleeding in cancer patients with thrombocytopenia undergoing surgery, chemotherapy and/or radiotherapy. While platelet transfusion may appear reasonable in many instances, greater scientific and medical attention should however be given to the possibly insidious impact of transfused platelets on the outcome of cancers. Indeed platelets and the microvesicles they release possess all the biological ingredients capable of supporting tumor growth, protecting circulating tumor cells, and to contributing to metastatic invasion. Until any randomized controlled trials can objectively document their effects on survival or cancer recurrence, minimizing the use of platelet transfusion in cancer patients appears to represent a reasonable precautionary measure.

Original languageEnglish
Pages (from-to)305-309
Number of pages5
JournalTransfusion and Apheresis Science
Volume56
Issue number3
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Platelet Transfusion
Neoplasms
Blood Platelets
Transfusion Medicine
Circulating Neoplastic Cells
Thrombocytopenia
Radiotherapy
Randomized Controlled Trials
Hemorrhage
Recurrence
Drug Therapy
Survival
Growth

Keywords

  • Cancer
  • Platelet
  • Progression
  • Transfusion

ASJC Scopus subject areas

  • Hematology

Cite this

Platelet transfusion in thrombocytopenic cancer patients : Sometimes justified but likely insidious. / Burnouf, Thierry; Elemary, Mohamed; Radosevic, Julia; Seghatchian, Jerard; Goubran, Hadi.

In: Transfusion and Apheresis Science, Vol. 56, No. 3, 01.06.2017, p. 305-309.

Research output: Contribution to journalReview article

Burnouf, Thierry ; Elemary, Mohamed ; Radosevic, Julia ; Seghatchian, Jerard ; Goubran, Hadi. / Platelet transfusion in thrombocytopenic cancer patients : Sometimes justified but likely insidious. In: Transfusion and Apheresis Science. 2017 ; Vol. 56, No. 3. pp. 305-309.
@article{33556266e2e54b23a66ab6d29a31e384,
title = "Platelet transfusion in thrombocytopenic cancer patients: Sometimes justified but likely insidious",
abstract = "The transfusion of platelet concentrates prepared from allogeneic single or pooled donations is a standard procedure in transfusion medicine to stop or prevent bleeding in cancer patients with thrombocytopenia undergoing surgery, chemotherapy and/or radiotherapy. While platelet transfusion may appear reasonable in many instances, greater scientific and medical attention should however be given to the possibly insidious impact of transfused platelets on the outcome of cancers. Indeed platelets and the microvesicles they release possess all the biological ingredients capable of supporting tumor growth, protecting circulating tumor cells, and to contributing to metastatic invasion. Until any randomized controlled trials can objectively document their effects on survival or cancer recurrence, minimizing the use of platelet transfusion in cancer patients appears to represent a reasonable precautionary measure.",
keywords = "Cancer, Platelet, Progression, Transfusion",
author = "Thierry Burnouf and Mohamed Elemary and Julia Radosevic and Jerard Seghatchian and Hadi Goubran",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.transci.2017.05.016",
language = "English",
volume = "56",
pages = "305--309",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Platelet transfusion in thrombocytopenic cancer patients

T2 - Sometimes justified but likely insidious

AU - Burnouf, Thierry

AU - Elemary, Mohamed

AU - Radosevic, Julia

AU - Seghatchian, Jerard

AU - Goubran, Hadi

PY - 2017/6/1

Y1 - 2017/6/1

N2 - The transfusion of platelet concentrates prepared from allogeneic single or pooled donations is a standard procedure in transfusion medicine to stop or prevent bleeding in cancer patients with thrombocytopenia undergoing surgery, chemotherapy and/or radiotherapy. While platelet transfusion may appear reasonable in many instances, greater scientific and medical attention should however be given to the possibly insidious impact of transfused platelets on the outcome of cancers. Indeed platelets and the microvesicles they release possess all the biological ingredients capable of supporting tumor growth, protecting circulating tumor cells, and to contributing to metastatic invasion. Until any randomized controlled trials can objectively document their effects on survival or cancer recurrence, minimizing the use of platelet transfusion in cancer patients appears to represent a reasonable precautionary measure.

AB - The transfusion of platelet concentrates prepared from allogeneic single or pooled donations is a standard procedure in transfusion medicine to stop or prevent bleeding in cancer patients with thrombocytopenia undergoing surgery, chemotherapy and/or radiotherapy. While platelet transfusion may appear reasonable in many instances, greater scientific and medical attention should however be given to the possibly insidious impact of transfused platelets on the outcome of cancers. Indeed platelets and the microvesicles they release possess all the biological ingredients capable of supporting tumor growth, protecting circulating tumor cells, and to contributing to metastatic invasion. Until any randomized controlled trials can objectively document their effects on survival or cancer recurrence, minimizing the use of platelet transfusion in cancer patients appears to represent a reasonable precautionary measure.

KW - Cancer

KW - Platelet

KW - Progression

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=85020454139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020454139&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2017.05.016

DO - 10.1016/j.transci.2017.05.016

M3 - Review article

C2 - 28606448

AN - SCOPUS:85020454139

VL - 56

SP - 305

EP - 309

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 3

ER -